Status about Commodity Specifications and Grade Division of Chinese Medicinal Alisma Rhizoma
Objective:To comprehensively investigate the current situation of the specification grade of Alisma Rhizoma,and lay a solid foundation for further revision of its commodity specification and grade standard.Methods:Based on literature survey,field visit and communication questionnaire method,the historical evolution,current status of standards,practical application status and key issues in the production areas and markets were analyzed.Results:Alisma Rhizoma is divided into two commodity specifications include"Si-chuan Alisma Rhizoma"and"Fujian Alisma Rhizoma"according to the base and origin.But the original plant of the mainstream com-modity Sichuan Alisma Rhizoma on the market has not been officially accepted by the existing commodity specification and grade stand-ards of Alisma Rhizoma,and Alisma Rhizoma Fresh Cut Pharmaceutical Material Commodities on the market have no product quality standard;In terms of grade,there is a lack of intrinsic quality indicators that reflect the efficacy of Alisma Rhizoma;Except for"Fujian Alisma Rhizoma",other Alisma Rhizoma which producted from other areas do not refer to existing standards in actual processing and trading,and the grade standards are extremely inconsistent.Conclusion:The specification and grade standards of Alisma Rhizoma have limited role in regulating and guiding production and marketing because of it no longer meet the basic principles of"pharmacopoeia-based"and"market-based".It is suggested that the standard revision of Alisma Rhizoma should focus on"Sichuan Alisma Rhizoma"and the fresh-cut pharmaceutical materials which are the mainstream commodities in the market now,so as to the standard can truly guide the formation of the"high-quality and high-price"system of Alisma Rhizoma in China,and promote the healthy development of Alisma Rhizoma high-quality industry with"high standards".
万方数据
维普
